Phillip Tai

About Phillip Tai

Phillip Tai, With an exceptional h-index of 28 and a recent h-index of 25 (since 2020), a distinguished researcher at University of Massachusetts Medical School,

His recent articles reflect a diverse array of research interests and contributions to the field:

Producing high-quantity and high-quality recombinant adeno-associated virus by low-cis triple transfection

Use of inverted terminal repeats (ITRS) from adeno-associated virus serotypes 8 and RH. 39 in gene therapy vectors

Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor

Profiling AAV vector heterogeneity & contaminants using next-generation sequencing methods

Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization

Aav capsid designs

Integration of gene therapy vectors: a risk factor for tumorigenesis or another commensal property of adeno-associated viruses that benefits long-term transgene expression?

Adeno-associated virus for delivery of kh902 (conbercept) and uses thereof

Phillip Tai Information

University

Position

___

Citations(all)

3950

Citations(since 2020)

3600

Cited By

1091

hIndex(all)

28

hIndex(since 2020)

25

i10Index(all)

36

i10Index(since 2020)

35

Email

University Profile Page

Google Scholar

Top articles of Phillip Tai

Producing high-quantity and high-quality recombinant adeno-associated virus by low-cis triple transfection

Molecular Therapy Methods & Clinical Development

2024/6/13

Use of inverted terminal repeats (ITRS) from adeno-associated virus serotypes 8 and RH. 39 in gene therapy vectors

2024/3/12

Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor

EMBO Molecular Medicine

2024/2/27

Profiling AAV vector heterogeneity & contaminants using next-generation sequencing methods

Cell and Gene Therapy Insights

2024/1/31

Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization

2023/12/26

Aav capsid designs

2023/11/23

Integration of gene therapy vectors: a risk factor for tumorigenesis or another commensal property of adeno-associated viruses that benefits long-term transgene expression?

2023/11/1

Adeno-associated virus for delivery of kh902 (conbercept) and uses thereof

2023/10/26

Use of novel mirna-binding site cassettes for antigen-presenting cell detargeting of transgene expression by raav gene therapy

2023/10/19

Learning to lock down genetic diseases without throwing away the key

Molecular Therapy

2023/7/5

Querying Recombination Junctions of Replication-Competent Adeno-Associated Viruses in Gene Therapy Vector Preparations with Single Molecule, Real-Time Sequencing

Viruses

2023/5/24

Aav capsids variants and uses thereof

2023/5/4

Recombinant adeno-associated virus for delivery of kh902 (conbercept) and uses thereof

2023/2/23

Adeno-associated virus vector platform for delivery of kh902 (conbercept) and uses thereof

2022/10/20

Transduction of self-complementary AAV in the Trabecular Meshwork and Anterior Chamber in mouse

Investigative Ophthalmology & Visual Science

2022/6/1

AAV-mediated anti-VEGF therapeutics increase corneal allograft survival-rate in a model of high-risk corneal transplantation

Investigative Ophthalmology & Visual Science

2022/6/1

Comparison of Adeno-Associated Virus Serotype Tropism in Human Retinal Explants and Non-Human Primates Retinal Explants

Investigative Ophthalmology & Visual Science

2022/6/1

Rational engineering of a functional CpG-free ITR for AAV gene therapy

Gene therapy

2022/6

262. Growing Clinical Gene Testing Considerations in the Era of RNA and Gene Therapy

Molecular Therapy

2022/4

Human and insect cell-produced recombinant adeno-associated viruses show differences in genome heterogeneity

Human Gene Therapy

2022/4/1

See List of Professors in Phillip Tai University(University of Massachusetts Medical School)